###begin article-title 0
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 51 54 51 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
Deletion Hotspots in AMACR Promoter CpG Island Are cis-Regulatory Elements Controlling the Gene Expression in the Colon
###end article-title 0
###begin p 1
Current address: Department of Pathology and Laboratory Medicine, University of Utah, Salt Lake City, Utah, United States of America
###end p 1
###begin p 2
Conceived and designed the experiments: XZ SMH. Performed the experiments: XZ IL. Analyzed the data: XZ IL RD MM SMH. Contributed reagents/materials/analysis tools: IL MPR RD ZJ SMH. Wrote the paper: XZ IL SMH.
###end p 2
###begin p 3
###xml 662 667 659 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 893 898 890 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 1515 1518 1512 1515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1740 1745 1737 1742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 1813 1820 1810 1817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1876 1881 1873 1878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 1921 1926 1918 1923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
Alpha-methylacyl-coenzyme A racemase (AMACR) regulates peroxisomal beta-oxidation of phytol-derived, branched-chain fatty acids from red meat and dairy products - suspected risk factors for colon carcinoma (CCa). AMACR was first found overexpressed in prostate cancer but not in benign glands and is now an established diagnostic marker for prostate cancer. Aberrant expression of AMACR was recently reported in Cca; however, little is known about how this gene is abnormally activated in cancer. By using a panel of immunostained-laser-capture-microdissected clinical samples comprising the entire colon adenoma-carcinoma sequence, we show that deregulation of AMACR during colon carcinogenesis involves two nonrandom events, resulting in the mutually exclusive existence of double-deletion at CG3 and CG10 and deletion of CG12-16 in a newly identified CpG island within the core promoter of AMACR. The double-deletion at CG3 and CG10 was found to be a somatic lesion. It existed in histologically normal colonic glands and tubular adenomas with low AMACR expression and was absent in villous adenomas and all CCas expressing variable levels of AMACR. In contrast, deletion of CG12-16 was shown to be a constitutional allele with a frequency of 43% in a general population. Its prevalence reached 89% in moderately differentiated CCas strongly expressing AMACR but only existed at 14% in poorly differentiated CCas expressing little or no AMACR. The DNA sequences housing these deletions were found to be putative cis-regulatory elements for Sp1 at CG3 and CG10, and ZNF202 at CG12-16. Chromatin immunoprecipitation, siRNA knockdown, gel shift assay, ectopic expression, and promoter analyses supported the regulation by Sp1 and ZNF202 of AMACR gene expression in an opposite manner. Our findings identified key in vivo events and novel transcription factors responsible for AMACR regulation in CCas and suggested these AMACR deletions may have diagnostic/prognostic value for colon carcinogenesis.
###end p 3
###begin title 4
Author Summary
###end title 4
###begin p 5
###xml 373 378 373 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 555 560 555 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 615 620 615 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 731 736 731 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 857 862 857 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 1146 1151 1146 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 0 3 <span type="species:ncbi:9606">Men</span>
Men consuming high amounts of red meat and dairy products are at a higher risk of developing colon and prostate cancer. Alpha-methylacyl-coenzyme A racemase (AMACR) is an enzyme that helps to break down fat from these foods to produce energy. An increase in the utilization of energy from fat is a hallmark of many cancers including colon and prostate cancers. Indeed, the AMACR gene was first found to be abnormally active in prostate cancers, and its abnormal expression has become a diagnostic marker for the cancer. However, little is known about how AMACR becomes activated in cancer cells. Here, we show that AMACR is also highly expressed in certain stages of colon cancer, though not all stages. A close examination of the AMACR gene in a panel of normal and progressively malignant colon tissues reveals that deletions of specific sequences in the AMACR gene may trigger its abnormal expression during the evolution of colon cancer. We also identify unique proteins known as "transcription factors" that normally bind to these deleted sequences to maintain normal expression of the gene. Finally, we report a new deletion variant of the AMACR gene in the general population that may influence the course of colon carcinogenesis.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 207 210 207 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Ferdinandusse1">[1]</xref>
###xml 729 732 723 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Baron1">[2]</xref>
###xml 877 880 868 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Zha1">[3]</xref>
###xml 942 947 933 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 1057 1060 1048 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Carnell1">[4]</xref>
###xml 1061 1064 1052 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Zha2">[5]</xref>
###xml 1296 1299 1287 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Rohrmann1">[6]</xref>
###xml 1300 1303 1291 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Levi1">[7]</xref>
###xml 1069 1075 <span type="species:ncbi:9606">humans</span>
Alpha-methylacyl-CoA racemase (AMACR) is a peroxisomal and mitochondrial enzyme that is indispensable in the catabolism of phytol-derived, 2-methyl-branched-chain fatty acids and the synthesis of bile acids [1]. In hepatocytes, AMACR catalyzes the conversion of pristanoyl-CoA and C27-bile acyl-CoAs from R- to S-stereoisomers, which are the only stereoisomers that can undergo beta-oxidation. Bile acid intermediates undergo one round of beta-oxidation in the peroxisomes and are secreted. In contrast, branched-chain fatty acid derivatives are transported to mitochondria, where they are further degraded to generate biological energy. Since most malignancies increase fatty acid utilization as an energy source to fuel growth [2], it has been suggested that increased beta-oxidation of branched-chain fatty acids provides transformed cells with a unique metabolic advantage [3]. This idea is supported by recent findings that knockdown of AMACR transcripts or inhibition of the racemase activity effectively blocked growth of prostate cancer (PCa) cells [4],[5]. In humans, the major sources of phytol-derived, 2-methyl-branched fatty acids are dietary ruminant fats, meat, and dairy products. Increased consumption of these foods are known risk factors for prostate and colon carcinoma (CCa) [6],[7].
###end p 7
###begin p 8
###xml 165 168 165 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Jiang1">[8]</xref>
###xml 169 172 169 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Xu1">[9]</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Ananthanarayanan1">[10]</xref>
###xml 276 280 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Luo1">[13]</xref>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Jiang3">[14]</xref>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Shi1">[18]</xref>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Jiang4">[19]</xref>
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Lin1">[21]</xref>
###xml 530 534 530 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Fearon1">[22]</xref>
###xml 651 656 651 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 666 669 666 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Zha2">[5]</xref>
###xml 720 724 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Kuefer1">[16]</xref>
###xml 725 729 725 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Mobley1">[23]</xref>
###xml 777 782 777 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 861 866 861 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 907 911 907 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Daugherty1">[24]</xref>
###xml 912 916 912 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Levin1">[25]</xref>
###xml 924 928 924 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Daugherty2">[26]</xref>
###xml 986 991 986 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
Aberrant expression of AMACR was first reported in PCa and high-grade prostatic intraepithelial neoplasia but not in benign hyperplastic lesions or normal epithelia [8],[9]. These findings quickly led to the establishment of AMACR as a reliable diagnostic marker for PCa [10]-[13]. More recently, overexpression of AMACR also was reported in CCa [14]-[18], with a prevalence between 45% and 75% [19]-[21]. However, the relationship between levels of AMACR expression and the sequence of adenoma-carcinoma progression in the colon [22] has not been fully characterized. Except for a report that identified a non-canonical CCAAT enhancer element in the AMACR promoter [5] and a lack of regulation of this gene by androgen [16],[23], no information is available regarding how the AMACR gene is regulated. Furthermore, although recent studies have identified a few AMACR gene variants to be associated with PCa [24],[25] or CCa [26] risks, a sequence polymorphism in the promoter region of AMACR has not been reported.
###end p 8
###begin p 9
###xml 115 120 115 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 137 144 137 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 409 414 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 652 657 652 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 860 863 860 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 974 979 974 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
Given the potential significance of AMACR in CCa, our objectives in this study were to determine the mechanisms of AMACR gene regulation in vivo during neoplastic transformation of the colon epithelium. Through the use of a comprehensive panel of immunostained-laser-capture-microdissected (iLCM) clinical samples comprising the entire colon adenoma-carcinoma sequence, we now report that the deregulation of AMACR during colon carcinogenesis involves non-random events, resulting in a double-deletion at CG3 and CG10, and alterations in the frequencies of deletion of CG12-16 in a newly identified CpG island (CGI) located within the core promoter of AMACR. We also identified deletion of CG12-16 as a putative regulatory polymorphism and the double-deletion at CG3 and 10 as a somatic lesion. The DNA sequences housing these deletions were indicated to be a cis-regulatory element for Sp1 and a putative ZNF202-binding site, respectively, and to exert opposite effects on AMACR transcription.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
Overexpression of AMACR in Villous Adenomas and in Well- and Moderately Differentiated CCas but not in Poorly Differentiated CCas
###end title 11
###begin p 12
###xml 331 346 331 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g001">Figure 1A to 1H</xref>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 494 503 494 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g001">Figure 1A</xref>
###xml 517 526 517 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g001">Figure 1B</xref>
###xml 597 606 597 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g001">Figure 1C</xref>
###xml 646 655 646 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g001">Figure 1D</xref>
###xml 665 681 665 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g001">Figure 1E and 1F</xref>
###xml 699 708 699 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g001">Figure 1G</xref>
###xml 863 872 863 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g001">Figure 1H</xref>
###xml 1138 1147 1138 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g001">Figure 1I</xref>
We first provided a detailed description of the relationship between AMACR expression levels and the sequence of adenoma-carcinoma progression in the colon. The levels of AMACR in 55 foci representing seven normal, premalignant and malignant histological entities in 35 colon specimens were semiquantified in immunostained slides (Figure 1A to 1H). These foci were subsequently microdissected for AMACR promoter studies. In general, AMACR immunostaining was negative to weak in normal cryptal (Figure 1A) and apical (Figure 1B) epithelia, as well as in tubular adenomas (TAs) with mild dysplasia (Figure 1C). In contrast, villous adenomas (VAs) (Figure 1D), well- (Figure 1E and 1F) and moderately (Figure 1G) differentiated adenocarcinomas expressed high levels of AMACR. AMACR immunostaining was almost absent to negligible in poorly differentiated carcinomas (Figure 1H). Compared with the expression in normal crypt, levels of AMACR expression, represented as a score of 0 to 4, were significantly increased in VAs and in well- and moderately differentiated carcinoma but not in normal apex, TAs, and poorly differentiated carcinoma (Figure 1I).
###end p 12
###begin title 13
Detection of AMACR expression level by immunostaining.
###end title 13
###begin p 14
###xml 264 272 264 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post hoc</italic>
###xml 340 341 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 670 671 666 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 766 767 760 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 894 895 886 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 946 947 936 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1011 1012 999 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1213 1214 1199 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1046 1054 <span type="species:ncbi:301928">ellipses</span>
A-H: the typical AMACR immunostaining found in normal and neoplastic colon sections from our case materials. I: AMACR expression scores of these foci, representing the above groups, depicted in a scatter plot. One-way analysis of variance, followed by Tukey's HSD post hoc test, indicated the significant difference among different groups (p<0.0001). The normal crypt group served as a reference. Foci with normal cryptal glands had very low AMACR expression (score: 0.22+/-0.22), with 8 of 9 foci scored negative. Foci with normal apical surface epithelium had mildly elevated expression (1.1+/-0.55) that was not statistically different from that of the former group (p = 0.67). Expression at foci harboring TA glands with a mild degree of dysplasia (0.22+/-0.15, p = 1.00) was not statistically different from that in normal cryptal glands. However, VAs had elevated expression (2.3+/-0.62, p = 0.007) comparable to that of well- (2.8+/-0.60, p = 0.001) and moderately differentiated carcinomas (2.7+/-0.49, p = 0.002); the three groups (open ellipses) have higher AMACR expression scores than normal and TAs. In marked contrast, AMACR expression scores in poorly differentiated cancers were low (0.14+/-0.14, p = 1.00), with 6 of 7 foci devoid of AMACR immunostaining.
###end p 14
###begin title 15
Organization of the AMACR Proximal Promoter Region
###end title 15
###begin p 16
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 72 79 72 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 235 244 235 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In silico</italic>
###xml 268 273 268 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 479 488 479 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g002">Figure 2A</xref>
###xml 722 731 722 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g002">Figure 2A</xref>
###xml 812 815 812 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Zha2">[5]</xref>
###xml 1115 1120 1115 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 1142 1147 1142 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 1276 1281 1276 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 1298 1305 1298 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1398 1407 1398 1407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 1502 1506 1502 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Wagner1">[27]</xref>
###xml 1506 1509 1506 1509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1542 1551 1542 1551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g002">Figure 2B</xref>
###xml 1739 1742 1739 1742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Zha2">[5]</xref>
###xml 1984 1994 1984 1994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Discussion</xref>
Because virtually no information is available on how AMACR is regulated in vivo, we initially were interested in determining if changes in DNA methylation status of the AMACR 5' flanking promoter region play a role in gene regulation. In silico analysis revealed that AMACR transcripts share the same first exon with an 88-bp 5' untranslated region (5' UTR), suggesting that the gene is controlled by one promoter. Two CGIs were identified flanking the transcription start site (Figure 2A). The first is a novel CGI located upstream of the ATG site (-230 to -60; the position of the translation start site was set as +1) with 18 CG dinucleotides, whereas the second CGI downstream of the ATG site (48 to 357, not shown in Figure 2A) has been reported and shown to not be involved in gene regulation in PCa cells [5]. In concordance, our pilot studies indicated that the downstream CGI exhibited no differences in methylation/deletion/mutation status among the histological entities of the colon (data not shown). Hence, subsequent studies were focused on analyses of the previously not reported proximal CGI in the AMACR promoter region (the AMACR promoter CGI). Our bisulfite sequencing data did not support the involvement of DNA methylation of this newly identified CGI in AMACR gene regulation in vivo, since the promoter is largely unmethylated in all 55 iLCM samples (next section). However, in silico analyses identified two putative Sp1 binding sites at CG3 and CG10 and a non-canonical ZNF202 [27]cis-element at CG12-16 of this CGI (Figure 2B). Variable frequencies of deletions were found at these sites and later shown to be involved in gene regulation (next section). A previously reported non-canonical CCAAT enhancer element [5] was aligned to CG5. Two direct repeat sequences, 7 bp in length, were noted to flank the transcription start site. We later proposed that these two repeated sequences are involved in the generation of the CG12-16 deletion (dotted lines; see Discussion below).
###end p 16
###begin title 17
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
The organization of AMACR gene 5'-flanking region.
###end title 17
###begin p 18
A: The location of the CpG island upstream translation start site (designated as +1). Individual CG sites are indicated as red vertical lines and numbered from 1 to 18. The 222-bp nested PCR-amplified CGI is illustrated. B: Partial exon 1 and the promoter sequence encompassing the CGI. The first exon is indicated by a bent arrow (TSS). Predicated transcription factor binding sites of Sp1 and ZNF202, together with the CCAAT enhancer binding site, are underlined. The locations of two pairs of primers for bisulfite sequencing PCR are blocked with different colors. The ChIP assay-amplified region is marked with brackets. The DNA upstream -4 (bent arrow, promoter clone) was cloned for promoter analysis. Two direct repeats of up to 7 nt (5'-GGCGCCG-3') that may related to the deletion caused by slipped-strand mispairing are marked by dotted lines. Primers PolyF/PolyR for polymorphism study are marked with the arrows. The wild type (WT) probe for gel shift assay targeting on putative ZNF202 binding site is boxed. Two short putative ZNF202 core sequences identified by MatInspector were highlighted in red.
###end p 18
###begin title 19
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
Identification of Deletion Hotspots in the Novel AMACR Promoter CGI in Colon Tissues
###end title 19
###begin p 20
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 89 97 89 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g002">Figure 2</xref>
###xml 418 425 418 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t001">Table 1</xref>
###xml 923 932 923 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g003">Figure 3A</xref>
###xml 974 983 974 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g003">Figure 3A</xref>
###xml 997 1006 997 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000334.s001">Figure S1</xref>
###xml 1030 1039 1030 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000334.s001">Figure S1</xref>
###xml 1142 1151 1142 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g003">Figure 3B</xref>
A 222-bp region encompassing all 18 CG sites in the newly identified AMACR promoter CGI (Figure 2) was analyzed for methylation, deletion, and mutation changes using DNA obtained from LCM samples and CCa cell lines. Bisulfite sequencing analyses of 239 alleles from 55 foci and regular DNA sequencing of 37 alleles from 9 foci as the control (also see next section) showed that most of the CG sites were unmethylated (Table 1). However, variable frequencies of deletions, methylation, and mutations were found to occur almost invariably at CG3, CG10, and CG12-16, with deletions as the predominant lesion among all aberrations. The sequences of these deletion and mutation variants were deposited to Genbank with the accession number from EF636492 to EF636496. Cluster analyses demonstrated that deletion of CG12-16 was the most common co-occurrence, followed by deletion at CG3 and CG10 (double-deletion at CG3 and CG10) (Figure 3A). Cluster analyses data for methylation (Figure 3A), mutations (Figure S1), and all aberrations (Figure S1) were also obtained. The number of deleted nucleotides (nts) was 2 to 8 nts at CG3 and 2 nts at CG10 (Figure 3B). Deletion at CG12-16 was found to be precisely 20 nts. Among the four CCa cell lines examined, CG12-16 deletions were found in SW480 and SW620; no double-deletion of CG3 and 10 was detected in any of these cell lines. Thus, while methylation of this novel CGI does not appear to play a role in gene regulation, deletions of specific sequences or deletion hotspots within this sequence were identified and might play critical roles in the regulation of gene expression and/or the adenoma-carcinoma progression.
###end p 20
###begin title 21
Bisulfite sequencing analysis of iLCM.
###end title 21
###begin p 22
###xml 637 642 637 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 700 705 700 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 776 797 776 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
The results were summarized from the status of 4302 CG sites from a total of 239 alleles in the entire set of 55 microdissected samples. A: Cluster analyses of the deletion and methylation to establish clusters of CG sites based on the entire sequencing data set. The average linkage was employed for hierarchical clustering (sites 1-18). The absolute number of co-occurrences of different CG deletions was used as the similarity measure. The higher the number of clones with two specific CG deletions, the closer they are in the dendrogram. The hotspots were restricted to CG3, 10, and 12-16. B: Typical bisulfite sequencing results of AMACR CGI with deletions highlighted in grey. The sequences of AMACR promoter variants have been deposited in Genbank and are described in Materials and Methods.
###end p 22
###begin title 23
Bisulfite sequencing analysis of iLCM samples.
###end title 23
###begin p 24
Genetic (deletion and mutation) and epigenetic (methylation) changes in each CG site. Pronounced alternations of the CG hotspots are in bold. Genetic changes outside the CG sites were rare and negligible (data not shown). Deletion, but not mutation or methylation, was the most commonly identified alteration.
###end p 24
###begin title 25
Deletion Hotspots Are Not Due to Artifacts from Bisulfite-Treatment, PCR or Sequencing
###end title 25
###begin p 26
###xml 308 313 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 590 600 578 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000334.s002">Figure S2A</xref>
As our focus on promoter assay will be based on the above sequencing results, we herein provide several pieces of data to ensure that the deletions were not artifacts of bisulfite-treatment of the DNA, PCR or sequencing. First, bisulfite modification reduced the GC content to approximately41% in the 222-bp AMACR promoter CGI, which made the sequencing easier to read; second, visual examination of sequencing chromatogram files showed clean and discrete peaks in the CGI region, indicating that the deletions we observed in bisulfite sequencing were not due to a GC compression artifact (Figure S2A). In addition, as an internal control to ensure complete bisulfite modification, we routinely examined and found that almost 100% of the non-CpG cytosines in this region were converted to T, indicating complete bisulfite modification.
###end p 26
###begin p 27
###xml 244 254 244 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000334.s002">Figure S2B</xref>
###xml 453 463 453 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000334.s002">Figure S2B</xref>
To demonstrate that the CG12-16 deletion was not due to the PCR artifact, we used sequencing-verified plasmids with or without CG12-16 deletion as PCR templates, the PCR products showed expected size with different positions in 3% agarose gel (Figure S2B, left panel). Additionally, we used unmodified (not shown) and bisulfite-treated genomic DNA, with or without the CG12-16 deletion, as templates and performed multiple PCRs on the same two samples (Figure S2B, right panel). Results demonstrated the sizes of the amplicons derived from wild-type and deletion-variant templates were consistent, indicating that the deletion of CG12-16 was neither a PCR artifact nor a result of bisulfite-treatment.
###end p 27
###begin p 28
###xml 356 361 356 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 392 402 392 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000334.s002">Figure S2C</xref>
###xml 83 88 <span type="species:ncbi:9606">human</span>
Blast searches provide additional evidence that the CG12-16 deletion exists in the human genome, as of the two genome sequences, one is the reference assembly that corresponds to the sequence (NT_006576.15) without CG12-16 deletion and the other is the Celera assembly (NW_922562.1) exhibiting the deletion, which exactly matches what we discovered in the AMACR promoter in clinical samples (Figure S2C).
###end p 28
###begin p 29
###xml 296 305 296 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
Finally, we conducted parallel bisulfite and regular sequencing on DNA isolated from LCM-captured normal or malignant colon epithelial cells from 9 colon specimens. Identical sequence results were obtained with the two methods (data not shown). Thus, in conclusion, these control experiments and in silico analyses demonstrate that the observed deletion hotspots in this CGI exist in colon tissues and are not results of artifacts generated from bisulfite-treatment, PCR or sequencing.
###end p 29
###begin title 30
Deletion of CG12-16 and Double CG3 and 10 Deletions Are Mutually Exclusive Molecular Events that Appear to Underlie AMACR Expression and CCa Development
###end title 30
###begin p 31
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 122 135 122 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t002">Table 2, left</xref>
###xml 226 233 226 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
We then investigated the relationship between deletion patterns in the AMACR promoter CGI and levels of AMACR expression (Table 2, left) in 55 iLCM samples to gain insight into how these deletions might affect gene expression in vivo. CG3-only deletions were rather common (13-41%) but were not correlated with AMACR expression, and CG10-only deletions were rare (0-5%). However, double CG3 and 10 deletions occurred at higher frequencies and invariably only in foci with no or little AMACR expression (17-28%, scores 0 and 1). In contrast, CG12-16 deletions were common (21-67%) and showed a positive correlation with the AMACR expression score. In total, foci with moderate and high AMACR expression (scores 2-4) had a high frequency of CG12-16 deletions (53-67%) and no double CG3 and 10 deletions.
###end p 31
###begin title 32
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
Deletion hotspots of AMACR CGI and their relation to the level of AMACR expression and colon histological entity.
###end title 32
###begin p 33
###xml 1469 1470 1439 1440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1472 1473 1442 1443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Samples were divided into five groups according to their AMACR expression score (Left) or into six groups according to their histologic entity (Right). Left: Deletion at CG3 (Delta3 only) fluctuated as AMACR expression level went from 0 to 4; deletion at CG10 (Delta10 only) was a rare (</=5%) event in colon cells; Notably, CG3 and 10 double-deletions (Delta3 & 10, bold) were the only deletions identified in groups with low AMACR expression (score: 0-1). Frequent CG12-16 deletion (Delta12-16 only, bold) was correlated with high AMACR expression (53%, 67% and 66%, respectively. Score: 2-4). The rest of deletion combinations (Delta3 & 12-16; Delta10 & 12-16; and Delta3, 10 & 12-16) were not found or were at a low level (<2.5%). Right: Double-deletions at CG3 and 10 were found only in the normal and TA samples and notably absent in VA and CCas of all grades. CG12-16 deletion was found in all the sample groups but occurred at higher frequencies in well- and moderately differentiated cancers (56% and 89%, respectively). In contrast, in the poorly differentiated cancers, the sequence of the CGI was largely unchanged (72%) with only 14% deletion of CG12-16. Mutual exclusion of deletion at CG12-16 and double-deletion at CG3 and 10 (0%) is one of the features of the samples studied. Compared with the moderately differentiated group that has the highest deletion rate, significant difference of CG12-16 deletion was identified in the asterisk marked groups (*, p<0.05).
###end p 33
###begin p 34
###xml 80 94 80 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t002">Table 2, right</xref>
###xml 701 712 689 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g001">Figure 1E&#8211;G</xref>
###xml 861 866 849 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 1126 1135 1102 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g001">Figure 1H</xref>
Next, we examined the type of deletions found in the six histological entities (Table 2, right) to determine their relationship to the adenoma-carcinoma progression paradigm. CG3-only deletions were commonly found among normal and CCa foci. In most cases, GC10 deletions occurred as double CG3 and 10 deletions found in normal epithelium and TA (24-25%). In contrast, the double-deletion was not identified in VA or in CCa of any grade. CG12-16 deletions were found in all six histological entities; however, their frequency markedly increased in well- (56%) and moderately (89%) differentiated cancers and correlated with high AMACR expression in these lesions (mean expression score approximately3; Figure 1E-G). It is of interest that the frequency of deletions of all kinds was low in poorly differentiated cancers; 72% of these foci have no lesions in the AMACR promoter CGI. Like all other CCas, they lack the deletion of CG3 and 10; the frequency of CG12-16 deletion in these CCas was low (14%), which correlates with negligible to low levels of AMACR expression in these lesions (mean expression score approximately0; Figure 1H). Compared with the CG12-16 deletion in the moderately differentiated group that has the highest deletion rate, statistic analysis indicated the deletion was significantly changed in the normal, TA, VA and poorly differentiated groups but not in the well differentiated group.
###end p 34
###begin p 35
###xml 41 48 41 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 192 199 192 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t002">Table 2</xref>
###xml 616 621 616 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 639 647 639 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Together these data showed an intriguing in vivo phenomenon. Consistently, in all the samples analyzed, deletion of CG12-16 are not co-existed with double CG3 and 10 deletions (frequency = 0; Table 2). Additionally, double-deletions at CG3 and 10 are found only in normal epithelium and TA and are not observed in VA and CCa of all grades. In contrast, CG12-16 deletions are associated with moderate and well differentiated CCa that express high AMACR but not in poorly differentiated cancers that show negligible AMACR expression. These findings provide the impetus for a study of the effects of these deletions on AMACR transcription an in vitro system (the HCT 116; see below).
###end p 35
###begin title 36
Deletion of CG12-16 Is a Polymorphism But the Deletions at CG3 and CG10 Are Somatic Lesions
###end title 36
###begin p 37
###xml 381 391 381 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000334.s002">Figure S2C</xref>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
To better understand the relevance of these deletions to colon carcinogenesis, we must ask if these deletions are results of genetic events occurring in somatic cells of the colon or are constitutional alleles exist in the general population. Before this study, the only information available is that a sequence (NW_922562.1) harboring the CG12-16 deletion in the Celera assembly (Figure S2C). No AMACR sequences with deletion at CG3 or CG10, or at both sites have been reported in genomic databases.
###end p 37
###begin p 38
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Deka1">[28]</xref>
###xml 253 258 253 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 323 332 323 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g002">Figure 2B</xref>
###xml 442 449 442 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t003">Table 3</xref>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t004">4</xref>
###xml 551 558 551 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t003">Table 3</xref>
###xml 560 561 560 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 714 715 714 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 858 863 858 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
We used randomly sampled genomic DNA isolated from whole blood of 96 individuals (48 males and 48 females) from a relatively homogeneous Caucasian population of northern German for our study [28]. A 173 bp region encompassing all 18 CG sites within the AMACR promoter CGI were analyzed by regular and bisulfite sequencing (Figure 2B). The CG12-16 deletion was found to be a sequence variant with an allele frequency of 43% in the population (Table 3 and 4). The observed genotype frequencies conform to the expectations of Hardy-Weinberg proportions (Table 3, p>0.05). Between male and female samples, chi-square test for the genotype difference and allele frequency differences are not statistically significant (p>0.05). In contrast, in these blood DNA samples, no other deletions or mutations were found at any of the other CG sites in this region of the AMACR CGI, including CG3 and CG10.
###end p 38
###begin title 39
The distribution of CG12-16 deletion polymorphism.
###end title 39
###begin p 40
###xml 286 287 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 402 403 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 440 441 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The 96 blood genomic DNA samples were from general individuals in a relatively homogeneous Caucasian population of northern German. Hardy-Weinberg equilibrium test showed within the males and females of this population, the distribution of genotype frequencies follows H-W expectation (p = 0.37 and 0.75, respectively); Chi-square test showed between male and female samples, the genotypic difference (p = 0.42) and the allelic difference (p = 0.31) are not statistically significant. In this population, the frequency of the CG12-16 deletion allele is 43%.
###end p 40
###begin title 41
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
The distribution of deletion, mutation and methylation in AMACR promoter CGI in whole blood DNA samples.
###end title 41
###begin p 42
No mutation was identified in the samples. Deletion hotspot (bold) was identified only at CG12-16, whereas the methylation hotspots (bold) were identified at CG3 and CG10.
###end p 42
###begin p 43
###xml 261 268 261 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t004">Table 4</xref>
###xml 411 418 411 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t001">Table 1</xref>
Interestingly, although deletions/mutations at CG3 and/or CG10 were not found by normal sequencing, bisulfite sequencing demonstrated that the two CG sites are methylation hotspots in blood DNA samples, exhibiting a prevalence of 16.7% and 11.1%, respectively (Table 4). These frequencies were higher than those observed in tissue samples in which deletion is the predominant type of lesion at these two sites (Table 1). The fact that both single and double deletions at CG3 and CG10 are completely absent in blood samples but occur at frequencies between 13-30% in colon tissue DNA indicates that they are somatic lesions.
###end p 43
###begin title 44
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
Deletion of CG12-16 and Double-Deletion of CG3 and 10 Exert Opposite Actions on AMACR Transcription
###end title 44
###begin p 45
###xml 25 32 25 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 158 163 158 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 179 187 179 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 209 214 209 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 405 410 405 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 482 485 482 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp1</italic>
###xml 490 496 490 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF202</italic>
###xml 591 596 591 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 686 695 686 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g004">Figure 4A</xref>
###xml 862 870 862 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR599</italic>
###xml 106 111 <span type="species:ncbi:9606">human</span>
To determine whether the in vivo deletions affect AMACR gene transcription, we first established that the human CCa cell line HCT 116 is a suitable model for AMACR promoter study in vitro. These cells express AMACR transcripts, have an intact promoter sequence with an unmethylated CGI (data not shown), and therefore should have an intact "transcriptional machinery," including transcription factors for AMACR expression. Real-time RT-PCR showed that this cell line expresses both Sp1 and ZNF202 at significant levels. We cloned a long (1,818 bp; -1821/-4) and a short (599 bp; -602/-4) 5' AMACR promoter sequence, both containing the newly identified CGI, into pGL3b reporter vector (Figure 4A). The two sequences showed comparable promoter activities in HCT 116 cells. These data suggest the localization of core promoter elements within the 599-bp sequence (AMACR599), which was used to derive all other mutants in this study.
###end p 45
###begin title 46
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 48 51 48 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
Deletion hotspots in AMACR promoter CGI are the cis-acting elements.
###end title 46
###begin p 47
###xml 31 39 31 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR599</italic>
###xml 103 112 103 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR1818</italic>
###xml 203 211 203 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR599</italic>
###xml 345 350 345 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 511 519 511 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR599</italic>
###xml 698 699 686 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 762 770 750 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post hoc</italic>
###xml 838 839 826 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1063 1064 1051 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1130 1131 1118 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1302 1303 1290 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1419 1420 1407 1408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
A: Promoter assays showed that AMACR599 with the CGI in it had promoter activity comparable to that of AMACR1818, suggesting that the 599 bp region is critical for the gene regulation. Thus, we selected AMACR599 for further investigation. The promoter activity was normalized as relative light units. B: The location of the deletion hotspots in AMACR promoter. Various sequence variants were compared with the wild-type promoter. A previously identified CCAAT box is illustrated. C: Compared with the wild-type AMACR599, deletion of CCAAT enhancer element at CG5, or in combination with other deletion hotspots at CG3, 10 and 12-16, significantly reduced the promoter activity (58approximately67%, p<0.0001, one-way analysis of variance, followed by Tukey's HSD post hoc test). No significant differences among the CCAAT deletion groups (p = 0.014 to 1) were observed. When the CCAAT enhancer was maintained intact, the single deletion at CG12-16 or in combination with deletion hotspots at CG3 and 10 resulted in an increase in the promoter activity by 83-105% (p<0.0001) but no significant difference among the deletion groups (p = 0.060 to 1). Further, when the CCAAT enhancer was maintained and CG12-16 was intact, deletion of either CG3 or CG10 did not change the promoter activity significantly (p = 0.26 and 0.69, respectively). In contrast, double-deletion at CG3 and 10 decreased the promoter activity by 69% (p<0.001).
###end p 47
###begin p 48
###xml 127 135 127 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR599</italic>
###xml 175 184 175 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g004">Figure 4B</xref>
###xml 281 284 281 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Zha2">[5]</xref>
###xml 577 586 565 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g004">Figure 4C</xref>
###xml 1066 1071 1030 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
To directly demonstrate that the deletion hotspots affect gene transcription, we generated deletion and/or mutation mutants of AMACR599 by targeting single or multiple sites (Figure 4B). Since a previous study reported gene-regulatory activity of the CCAAT enhancer aligned to CG5 [5], we also included deletion mutants targeting this sequence in our study. Reporter assays performed in HCT 116 cells showed that deletion of the CCAAT enhancer sequence at CG5 led to a marked reduction in promoter activity (approximately60%) regardless the integrity of CG3, CG10, or CG12-16 (Figure 4C). However, in the presence of an intact CCAAT enhancer, deletion of CG12-16, in the absence or presence of CG3, CG10, or double CG3 and 10 deletions, resulted in augmentation of promoter activity (approximately100%). In contrast, deletion of CG3 and 10, but not a single deletion of either CG3 or CG10, caused a significant loss of promoter activity (approximately60%). These findings indicate that deletion of CG12-16 and double-deletion of CG3 and 10 exert opposite actions on AMACR transcription.
###end p 48
###begin p 49
To demonstrate that these regulatory mechanisms are not limited to CCas, we transfected these mutants into two PCa cell lines (PC-3 and LNCaP) and similar data were obtained (data not shown).
###end p 49
###begin title 50
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
Deletion Hotspots Are Located in cis-Elements Previously Not Known to Regulate AMACR Gene Expression
###end title 50
###begin p 51
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 82 91 82 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In silico</italic>
###xml 230 239 230 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g002">Figure 2B</xref>
###xml 275 284 275 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 436 443 436 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 499 503 499 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Jin1">[29]</xref>
###xml 504 508 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Rabinovich1">[30]</xref>
###xml 723 732 723 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 911 915 911 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-</italic>
###xml 948 957 948 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g002">Figure 2B</xref>
We next sought to understand how these deletions affect AMACR gene transcription. In silico analyses suggest the localization of Sp1 binding sites at CG3 and CG10 and a non-canonical ZNF202 binding site within the CG12-16 region (Figure 2B). However, it should be noted that in silico-based prediction requires experimental confirmation since recent ChIP-chip results have demonstrated a weak match between many consensus sequences and in vivo binding sites for specific transcription factors (TFs) [29],[30]. Poor correlations could be due a high degree of degeneracy for some motifs and/or the participation of other proteins at the binding sites. A series of confirmation studies were therefore performed to support our in silico-based predictions. We predict that deletion at CG3 or CG10 affects one of the two putative Sp1 binding sites, and deletion at CG12-16 impede occupancy of a ZNF202 protein to its cis-element located between CG12-16 (Figure 2B).
###end p 51
###begin p 52
###xml 220 242 220 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g005">Figure 5A, upper panel</xref>
###xml 315 320 315 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 322 344 322 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g005">Figure 5B, lower panel</xref>
###xml 382 385 382 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp1</italic>
###xml 406 411 406 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 465 474 465 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g005">Figure 5B</xref>
###xml 516 534 516 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">glucuronidase &#946;</italic>
###xml 536 540 533 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GUSB</italic>
###xml 545 558 542 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclophilin A</italic>
###xml 560 564 557 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
Using nuclear extracts from HCT116 cells, chromatin immunoprecipitation (ChIP) experiments were performed. Sp1 was found binding to a 174-bp sequence (-234/-60) that contains the two putative Sp1-sites at CG3 and CG 10 (Figure 5A, upper panel) but not to a 169-bp sequence (19553/19721) located in the last exon of AMACR (Figure 5B, lower panel). Small interfering (si)RNA-mediated Sp1 knockdown decreased AMACR mRNA expression at the second-round of transfection (Figure 5B) but did not reduce transcript levels of glucuronidase beta (GUSB) or cyclophilin A (PPIA), two unrelated genes (data not shown), in HCT 116 cells.
###end p 52
###begin title 53
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
Transcription factors Sp1 is involved in AMACR gene regulation in HCT 116 cells.
###end title 53
###begin p 54
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 110 119 110 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g002">Figure 2B</xref>
###xml 281 301 281 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g005">Figure 5A, top panel</xref>
###xml 378 383 378 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 500 522 500 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g005">Figure 5A, lower panel</xref>
###xml 543 546 543 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp1</italic>
###xml 571 576 571 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 666 669 666 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp1</italic>
###xml 692 693 692 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 735 738 735 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp1</italic>
###xml 779 780 779 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 853 858 853 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 871 872 871 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 928 933 928 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 956 957 956 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1058 1061 1058 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp1</italic>
###xml 1077 1081 1077 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GUSB</italic>
###xml 1086 1090 1086 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PP1A</italic>
Putative Sp1 binding site at CG3 and 10 were identified. A: ChIP assay with Sp1 antibody targeting AMACR CGI (Figure 2B). A PCR signal was detected in the Sp1 antibody ChIP with genomic DNA and normal IgG-immunoprecipitated DNA as the PCR input and negative control, respectively (Figure 5A, top panel). As a ChIP negative control, amplification of a region in the last exon of AMACR gene distant to the putative Sp1 sites was included in the experiment. Only the DNA input showed the amplification (Figure 5A, lower panel). B: siRNA-mediated Sp1 knockdown decreased the AMACR transcript level. Real-time RT-PCR demonstrated that the first-round siSp1 decreased the Sp1 transcript level 48% (p<0.001). With the second-round siSp1, the Sp1 transcript level further decreased 64% (p<0.001). In parallel, the first-round siSp1 resulted in little change in AMACR mRNA level (p = 0.66). Notably, the second-round siSp1 decreased the AMACR transcript level 53% (p = 0.002). In the negative control experiments, the same set of cDNA was used and siRNA knockdown of Sp1 did not affect GUSB and PP1A gene expression (data not shown).
###end p 54
###begin p 55
###xml 207 212 207 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 236 245 236 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g006">Figure 6A</xref>
###xml 312 314 312 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 547 551 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Wagner1">[27]</xref>
###xml 661 665 661 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Cartharius1">[31]</xref>
###xml 903 912 903 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g006">Figure 6B</xref>
###xml 991 999 991 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR599</italic>
###xml 1049 1054 1049 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 1061 1070 1061 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g006">Figure 6C</xref>
Since there is no commercially available ZNF202 antibody for ChIP, gel shift assays were performed to assess HCT 116 nuclear protein binding to the putative ZNF202 binding site located within CG12-16 of the AMACR CGI. As can be seen in Figure 6A, one specific protein-DNA complex (arrow) was formed on the 45-bp 32P-labeled double-stranded oligonucleotide (ODN) encompassing CG12-16 and its flanking sequences (Probe WT). The formation of this complex could be impeded by 100-fold excess of unlabeled WT or a 26-bp ZNF202 consensus sequence (GnT; [27]). However, it is resistant to competition by 100-fold excess of a 45-bp mutant with the ZNF202 core sequence [31] mutated (Mut) or a 32-bp ODN devoid of CG12-16 (Del). Interestingly, protein-DNA complex formation patterns on labeled WT and Del were different with notable absence of the lower band that could be competed off by excess cold WT or GnT (Figure 6B). Finally, ectopic expression of ZNF202 induced a dose-dependent reduction of AMACR599 promoter activity and concordant lower levels of AMACR mRNA (Figure 6C).
###end p 55
###begin title 56
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
ZNF202 is involved in AMACR gene regulation in HCT 116 cells.
###end title 56
###begin p 57
###xml 7 9 7 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 111 118 111 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t005">Table 5</xref>
###xml 899 904 899 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 1020 1028 1020 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR599</italic>
###xml 1070 1071 1070 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1158 1163 1154 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 1170 1171 1166 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
A: The 32P labeled wild type (WT) probe corresponds to a sequence containing CG12-16 and its flanking regions (Table 5). Gel shift assays showed a single, specific shifted band (arrow) whose signal intensity could be impeded by co-incubation with 100x excess cold WT probe or a ZNF202 consensus sequence (GnT) but not by 100x excess mutated (Mut) or CG12-16 deleted (Del) ODNs. The other shifted bands represent unknown protein-DNA complexes formation. B, Left: Using labeled WT as a probe three major shifted bands were identified. Signal intensities of these bands could not be reduced by co-incubation with excess cold Del ODN that has deletion of CG12-16. Right: Using labeled Del as probe, one major band that differs from those observed with the labeled WT was identified. Its signal intensity was not diminished by co-incubation with excess cold WT. C: Ectopic expression of ZNF202 decreased AMACR promoter activity and mRNA level in a dose-dependent manner. Co-transfection of the ZNF202 expression plasmid with AMACR599 (10 ng) decreased the promoter activity (p = 0.007); in parallel, ectopic expression of ZNF202 (2 microg) decreased the level of AMACR mRNA (p = 0.009). The asterisks indicate a significant difference in the group compared with the control.
###end p 57
###begin title 58
Primers and oligonucleotides used in this study.
###end title 58
###begin p 59
###xml 326 332 326 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">apoAIV</italic>
###xml 349 353 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Wagner1">[27]</xref>
Underlined: Promoter construction and ZNF202 expression, restriction sites for cloning; Gel shift assay probe WT, putative ZNF202 core sequence (MatInspector) flanking the CG12-16 region; Mut, mutated WT probe in the putative ZNF202 core sequence with C to T and G to A substitution; GnT, ZNF202 GnT consensus sequence in the apoAIV promoter region [27].
###end p 59
###begin p 60
###xml 112 115 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 159 164 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
In sum, these findings provide evidence in support of CG3 and CG10 as Sp1 binding sites and CG12-16 as a ZNF202 cis-element. Sp1 and ZNF202 appear to regulate AMACR expression in an opposite manner.
###end p 60
###begin title 61
Discussion
###end title 61
###begin p 62
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 237 242 237 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Esteller1">[32]</xref>
###xml 396 401 396 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 532 539 532 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 737 744 737 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 903 908 903 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
The main objective of this study was to elucidate the regulatory mechanism underpinning AMACR gene expression in relation to CCa development. We identified a novel CGI upstream the translation start site in the proximal core promoter of AMACR. Although aberrant methylation of promoter CGIs is a common cause of transcriptional deregulation of genes involved in tumorigenesis [32], we found that AMACR activation did not occur by this mechanism during colon carcinogenesis. Instead, we found that two non-random, mutually exclusive in vivo events, involving a double-deletion at CG3 and 10 and the deletion of CG12-16, play essential but opposite roles in the process. Additionally, we discovered the differential "origins" of these two in vivo deletions by comparing sequencing data from blood DNA in a general population and those from LCM-microdissected colon samples. The deletion of CG12-16 in the AMACR 5' CGI was found to be a constitutional allele with a frequency of 43% in a general population. In contrast, deletions at CG3 and/or CG10 were not observed in the blood samples indicating that these are genetic events occurring in somatic cells of the colon.
###end p 62
###begin p 63
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 362 365 362 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Zha1">[3]</xref>
###xml 366 369 366 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Carnell1">[4]</xref>
###xml 854 859 854 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 1021 1028 1021 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
We observed a strong positive correlation between AMACR expression and the sequence of adenoma-carcinoma progression, suggesting a promotional function of AMACR in colon carcinogenesis. This postulate agrees with recent studies reporting that siRNA-mediated knockdown of AMACR mRNA or inhibition of the enzyme activity effectively curbed the growth of PCa cells [3],[4]. Intriguingly, both gene expression and CCa progression were closely correlated with the status of two mutually exclusive deletions found in the iLCM samples. Specifically, the double CG3 and 10 deletion was found only in histologically normal colonic glands and TAs that had negligible to absent AMACR expression and was absent in VA or CCas of all grades that had variable levels of AMACR expression. More important, the simultaneous deletion of these two sites effectively negated AMACR transactivation in HCT 116. We therefore propose that deletion at CG3 and 10 may effectively obviate colon carcinogenesis, possibly by impeding AMACR expression in vivo. In this regard, adenomas harboring double-deletions of CG3 and 10 might have a low likelihood of development to CCas; its potential diagnostic value merit further study.
###end p 63
###begin p 64
###xml 350 355 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 630 634 630 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Benito1">[33]</xref>
In contrast to CG3 and 10 double-deletions, deletions of CG12-16 were highly prevalent in well- and moderately differentiated CCas that strongly expressed AMACR. This finding is impressive because it stands in stark contrast with the classical view that deletions cause functional inactivation of genes. In this instance, the CG12-16 deletion in the AMACR promoter CGI behaves like a "gain-of-function" deletion. When viewed in this context, the CG12-16 deletion may be part of the sequential genetic changes that occur in tumor suppressors, DNA repair genes, and oncogenes during the development of CCas from adenomatous lesions [33].
###end p 64
###begin p 65
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
Unlike the better differentiated CCas, most poorly differentiated cancers had a low percentage of deletions at CG12-16 and lacked AMACR expression. These cancers also had very few other aberrations including the double-deletion at CG3 and 10, in their AMACR promoter CGI. Because the gene is not silenced by DNA methylation, or by irreversible genetic events such as deletions, we have to consider the possibility that these cancers may have a clonal origin different from that of the better differentiated carcinomas. Alternatively, during their evolution, these cancers may acquire a metabolic phenotype that is independent of AMACR overexpression.
###end p 65
###begin p 66
###xml 178 185 178 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t003">Table 3</xref>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t004">4</xref>
###xml 258 265 258 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t001">Table 1</xref>
###xml 425 439 413 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t001">Table 1, row 1</xref>
###xml 782 783 758 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Much could be learned about the relationship between the CG12-16 deletion polymorphism and CCa risk by comparing the allelic frequency of this sequence variant in blood samples (Table 3 & 4) to those found in LCM-captured histological entities of the colon (Table 1). The overall allelic frequency of this deletion amongst the 239 alleles from the various histological entities of the colon was found to be approximately42% (Table 1, row 1), which matches the allele frequency observed in the blood samples is approximately43%. This suggests that there may not be additional somatic events altering the frequency of this constitutional sequence in the colon. Yet, the prevalence of this lesion reaches 89% in the moderately differentiated CCas, which showed significant difference (p<0.05) compared to the normal, TA, VA and poorly differentiated but not the well differentiated samples. Collectively, these data adds up to the hypothesis that individuals with the CG12-16 deletion variant are more likely to develop CCas that are well or moderately differentiated. Conversely, those carrying the wild type variant may be more prone to develop poorly differentiated CCas. Clearly, such a provocative hypothesis would have to await a well-designed population study for confirmation.
###end p 66
###begin p 67
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 173 176 173 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 292 297 292 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 359 364 359 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 428 431 428 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp1</italic>
###xml 452 457 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 565 570 565 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
Contributing significantly to our understanding of how AMACR is regulated, we here provide the first evidence that deletion hotspots in the AMACR promoter CGI correspond to cis-elements for Sp1 and that this transcription factor regulates AMACR expression. Our data support the regulation of AMACR by Sp1, as ChIP assays showed Sp1 binding to a region of the AMACR promoter CGI containing the predicted sites and siRNA-mediated Sp1 knockdown decreased AMACR mRNA levels in HCT 116. Reporter assays revealed that single deletion at either CG3 or CG10 did not affect AMACR transcription, whereas the double-deletion significantly abrogated the promoter activity, suggesting that the integrity of one site at either CG3 or CG10 is sufficient to maintain the promoter activity.
###end p 67
###begin p 68
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 455 460 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 644 647 644 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
In contrast, deletion of CG12-16 enhanced AMACR transcription, signifying the likely presence of a repressor binding site in this region. We did not perform a ChIP assay for ZNF202 because no antibody was commercially available for the immunoprecipitation. However, results from gel shift assays were highly suggestive of the existence of a non-canonical ZNF202 binding site within this sequence. Our finding that ectopic overexpression of ZNF202 reduced AMACR promoter activity lends credence to this notion. However, we are aware of the fact that these data did not provide the definitive evidence that the CG12-16 sequence contains a ZNF202 cis-element, which still awaits a formal demonstration in future investigations. It is always possible that some unknown transcription factors other than ZNF202 could be involved in this regulation.
###end p 68
###begin p 69
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Wagner1">[27]</xref>
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Langmann1">[34]</xref>
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Stene1">[35]</xref>
###xml 207 212 207 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">apoA4</italic>
###xml 214 218 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">apoE</italic>
###xml 220 256 220 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lecithin cholesterol acyltransferase</italic>
###xml 258 276 258 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lipoprotein lipase</italic>
###xml 282 311 282 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phospholipid transfer protein</italic>
###xml 377 380 377 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 468 473 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 499 502 499 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 543 548 543 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 803 807 803 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Wang1">[36]</xref>
###xml 808 812 808 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Trichopoulou1">[38]</xref>
###xml 897 902 897 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 1143 1146 1143 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Baron1">[2]</xref>
Intriguingly, ZNF202 is a transcriptional repressor for genes affecting the vascular endothelium as well as lipid metabolism. We have examined the promoters of five other ZNF202 target genes [27],[34],[35] (apoA4, apoE, lecithin cholesterol acyltransferase, lipoprotein lipase, and phospholipid transfer protein) and did not find deletions or other aberrations in their ZNF202 cis-element in colon and prostate cancer cells (unpublished data). Thus, the activation of AMACR via deletion of a ZNF202 cis-element would be a phenomenon unique to AMACR gene regulation, if the CG12-16 sequence was shown to house this element. Several epidemiologic and animal studies have observed associations between the risk of metabolic syndromes/coronary heart diseases and the prevalence of colon adenomas/carcinomas [36]-[38]. Perhaps the loss of ZNF202-mediated repression of specific target genes, including AMACR, is a common cause of these diseases. Apropos of this view, carcinogenesis is being recognized increasingly as a metabolic disorder characterized by a shift from glycolysis to fatty acid utilization as the energy source fueling cell growth [2].
###end p 69
###begin p 70
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 260 263 260 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
Finally, deletion of the CCAAT enhancer resulted in the loss of promoter activity regardless of the status of other elements, indicating that CCAAT enhancers are part of the basal transcriptional complex for AMACR. However, we did not find alterations in this cis-element in the iLCM samples, suggesting that such alterations do not contribute to aberrant expression of AMACR during colon carcinogenesis.
###end p 70
###begin p 71
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 173 180 173 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t001">Table 1</xref>
###xml 185 192 185 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t004">Table 4</xref>
###xml 263 267 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Pfeifer1">[39]</xref>
###xml 284 294 284 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000334.s003">Figure S3A</xref>
###xml 367 376 367 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g002">Figure 2B</xref>
###xml 432 436 432 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Efstratiadis1">[40]</xref>
###xml 437 441 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-OronKarni1">[41]</xref>
###xml 517 527 517 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000334.s003">Figure S3B</xref>
###xml 617 622 617 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
At present, it is unclear how the deletions at in the AMACR promoter arise. However, first, we noticed that deletion hotspots at CG3 and CG10 are also methylation hotspots (Table 1 and Table 4). It has been reported that methylated CG sites are mutation hotspots [39] as suggested in Figure S3A. Second, scrutiny of the CGI sequence revealed two 7 nt direct repeats (Figure 2B). We postulated that forward slipped-strand mispairing [40],[41] of the repeats, may result in the CG12-16 deletion during DNA replication (Figure S3B). If this mispairing happens, such slippage will cause the exact 20 bp deletion found in AMACR promoter. These proposed mechanisms speculated to be responsible for these deletions will of course have to await future experiments for corroboration.
###end p 71
###begin p 72
###xml 47 54 47 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 546 549 546 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 637 642 637 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 743 748 743 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
Collectively, we identified two major types of in vivo deletions in the AMACR promoter that appear to modulate gene expression and may play contrasting roles in carcinogenesis. In essence, a double-deletion at CG3 and 10 prevents AMACR overexpression and may impede colon carcinogenesis. In contrast, carriers of sequence variants with or without the CG12-16 deletion may have different propensity to develop well/moderately differentiated CCas versus the poorly differentiated cancers. Finally, our data suggest that these deletion hotspots are cis-elements for Sp1 at CG3 or CG10 and for ZNF202 at CG12-16. The proposed mechanisms for AMACR promoter regulation and the deletion hotspots provided important platforms for the further study of AMACR gene deregulation during carcinogenesis.
###end p 72
###begin title 73
Materials and Methods
###end title 73
###begin title 74
Samples
###end title 74
###begin p 75
###xml 1122 1126 1122 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Deka1">[28]</xref>
Archival specimens were obtained from the Department of Pathology at the University of Massachusetts Medical School. Specimens from 35 cases were immunostained and microdissected to obtain the 55 iLCM samples: 11 TAs with mild dysplasia, 8 VAs, 6 well differentiated carcinomas, 6 moderately differentiated carcinomas, 7 poorly differentiated carcinomas, and 17 histologically normal colon tissues with 9 normal crypt and 8 apical surface epithelial samples. For the TAs, pronounced dysplastic changes, which often linked to positive AMACR, were uncommon. Most of the foci had mild dysplastic changes, and we focused our study of TAs on this type of sample. These samples were used for bisulfite sequencing analysis. Specimens for nine additional cases were obtained from the Pathology Department of the University of Cincinnati Medical Center and used to obtain nine LCM samples of normal epithelial, adenomatous, and carcinomatous cells for a regular DNA sequencing for comparison with bisulfite sequencing. Blood samples for polymorphism assay were from a relatively homogeneous Caucasian population of northern German [28]. The use of these samples was reviewed and approved by the respective institutional review boards at the two institutions.
###end p 75
###begin title 76
Immunohistochemistry and Laser-Captured Microdissection
###end title 76
###begin p 77
###xml 328 331 328 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Jiang1">[8]</xref>
###xml 332 336 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Leav1">[42]</xref>
###xml 635 639 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Leav2">[43]</xref>
Multiple sections were cut from each case specimen. One section was stained with hematoxylin and eosin (H&E) and used for identification of histologic entities. The others were immunostained for AMACR with the P504S antibody (Dako Cytomation, Carpinteria, CA) and lightly counterstained with hematoxylin as previously described [8],[42]. Areas representative of the histologic features and the overall intensity of AMACR expression found in a given case were identified in immunostained sections. These areas were then located in the replicate. The coverslips were then removed, H&E-stained, and microdissected as previously described [43].
###end p 77
###begin title 78
Evaluation of AMACR Protein Expression
###end title 78
###begin p 79
Each of microdissected foci was given a score (0-4) reflective of the level of AMACR expression. When uniformly intense immunostaining was observed in at least 95% of cells in the section, the level of AMACR expression was designated as very strong (score = 4). If staining was less intense, not uniform throughout the section, and in fewer than 95% of the cells, the level of expression was designated as strong (score = 3). If the intensity of stain was weak, not uniform, and in 50% or fewer the cells, the section was graded as medium (score = 2) or weak (score = 1). Cases were scored as negative (score = 0) when the section showed no staining.
###end p 79
###begin title 80
Bisulfite Sequencing and Regular DNA Sequencing Analysis
###end title 80
###begin p 81
###xml 402 407 398 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 499 506 495 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t005">Table 5</xref>
###xml 511 519 507 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g002">Figure 2</xref>
###xml 705 708 701 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 1149 1156 1133 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t005">Table 5</xref>
###xml 117 122 <span type="species:ncbi:4932">yeast</span>
Genomic DNA was extracted from the LCM samples by DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA) with 20 microg of yeast tRNA added as a carrier. DNA was bisulfite-modified with the CGenome DNA Modification Kit (Millipore, Billerica, MA). Sequencing service was provided by Macrogen (Seoul, Korea) with BigDye terminator used in a 96-capillary 3730xl DNA analyzer. Bisulfite-sequencing PCR-targeting AMACR promoter CGI was conducted by nested PCR. Primers AM-bisF1/AM-bisR1 and AM-bisF2/AM-bisR2 (Table 5 and Figure 2) were used in the first round and nested PCR, respectively. The targeting region was from -276 to -55, with the translation start site designated as +1. PCR was performed with platinum Taq (ABI/Invitrogen, Carlsbad, CA) for 38 cycles with the annealing temperature at 56degreesC and 57degreesC in the first and nested PCR, respectively. Amplified fragments were purified in 1% agarose gel, TA-cloned, and about five colonies were picked from each sample for sequencing. Regular sequencing of the same CGI flanking region was performed in parallel using unmodified DNA samples and the regular primers AM-F1/AM-R1 and AM-F2/AM-R2 (Table 5). Proper controls were included in all experiments to ensure that the findings were not confounded by incomplete bisulfite modification, PCR artifact, or sequencing errors.
###end p 81
###begin title 82
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
Polymorphism Study in AMACR Promoter
###end title 82
###begin p 83
###xml 201 204 201 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 238 245 238 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t005">Table 5</xref>
###xml 250 258 250 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g002">Figure 2</xref>
###xml 840 845 834 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
Blood genomic DNA for the polymorphism study was extracted by DNeasy Blood & Tissue Kit. Using 50 ng genomic DNA as template, the PCR was performed for 40 cycles in the presence of 5% DMSO by platinum Taq with PolyF/PolyR as the primers (Table 5 and Figure 2). The annealing temperature was set at 58degreesC. The expected PCR product encompassing CpG sites 1-18 without CG12-16 deletion is 173 bp in length. After gel purification, the PCR products were TA cloned and the plasmids in colonies were directly amplified for sequencing by the Rolling Circle Amplification Kit (GE Health Care, Piscataway, NJ). PCR products from alleles with the deletion of CG12-16 could also be visualized by a size difference from amplicons derived from wild type alleles in a 3% agarose gel. To determine the prevalence of methylation in this region of the AMACR promoter, aliquots of the extracted genomic DNA was subjected to bisulfite sequencing.
###end p 83
###begin title 84
Promoter Construction and 5'- and Site-Specific Deletions
###end title 84
###begin p 85
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 153 160 153 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t005">Table 5</xref>
###xml 162 165 162 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 211 215 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hind</italic>
###xml 395 400 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 495 500 495 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
The AMACR promoter region immediately upstream of the translation start site was amplified from genomic DNA of HCT116 cells. With forward primer pAM-F1 (Table 5, XhoI site underlined) and reverse primer pAM-R0 (HindIII site underlined) used in PCR, the resulting 1818-bp AMACR promoter (from -1821 to -4) was cloned into luciferase reporter vector pGL3b (Promega, Madison, WI) and designated as AMACR1818. The promoter sequence was verified by sequencing. A 5' truncated promoter (designated as AMACR599, from -602 to -4) was generated by nested PCR with PAM-F2/PAM-R0 as the primers. Promoter site-specific deletion variants were obtained by using the Genetailor site-directed mutagenesis kit (Invitrogen). After sequencing, the promoter variants were released from the cloning vector and recloned into pGL3b.
###end p 85
###begin title 86
Cell Culture, Transfection, and Promoter Luciferase Assay
###end title 86
###begin p 87
###xml 378 379 378 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 584 588 580 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ</italic>
###xml 901 905 893 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Zhang1">[44]</xref>
###xml 100 105 <span type="species:ncbi:9606">Human</span>
###xml 564 567 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 595 598 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
All reagents used for cell cultures, including heat-inactivated FBS, were obtained from Invitrogen. Human CCa cell lines HCT 116, SW480, SW620, and DLD-1 were obtained from the American Type Culture Collection (Manassas, VA). The cells were maintained in the same condition as HCT 116 cells, which are cultured according to the provider's recommendations. Unless specified, 6x104 HCT 116 cells were plated one day before transfection in each well of the 24-well plate. The cells were transfected with a total of 0.2 microg of DNA, including 10 ng of cotransfected CMV promoter-driven LacZ gene (CMV-LacZ) as the internal control. Plasmids for transfection were purified with the EndoFree Plasmid Maxi Kit from Qiagen. Two microliters of Plus and 1 microl of Lipofectamine (Invitrogen) were used in the transfection according to the protocol. The promoter activity was analyzed as previously described [44].
###end p 87
###begin title 88
Chromatin Immunoprecipitation (ChIP)
###end title 88
###begin p 89
###xml 274 281 270 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t005">Table 5</xref>
###xml 314 317 310 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 606 613 578 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t005">Table 5</xref>
###xml 143 149 <span type="species:ncbi:9986">rabbit</span>
###xml 166 169 <span type="species:ncbi:9685">cat</span>
The ChIP assay was performed with the EZ ChIP Kit from Millipore according to the manufacture's instruction. A total of 7.5 microg of anti-Sp1 rabbit polyclonal IgG (cat. no. 07-645, Upstate/Millipore) was used in each IP. Primers Sp1-IPf/Sp1-IPr targeting -234 to -60 CGI (Table 5) were used in PCR with platinum Taq in the presence of 5% DMSO with an initial denaturation at 94degreesC for 1 min, followed by 36 cycles of 94degreesC for 30 sec, 58degreesC for 30 sec, and 72degreesC for 15 sec. As a negative control for DNA IP, primers ChIPnegF/ChIPnegR targeting the gene's last exon were used in PCR (Table 5).
###end p 89
###begin title 90
Real-Time RT-PCR
###end title 90
###begin p 91
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Zhang1">[44]</xref>
###xml 174 179 174 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 184 187 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp1</italic>
###xml 242 249 242 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t005">Table 5</xref>
###xml 286 290 286 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GUSB</italic>
###xml 295 299 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PP1A</italic>
###xml 357 364 357 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t005">Table 5</xref>
###xml 427 440 427 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
###xml 495 499 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Zhang1">[44]</xref>
###xml 500 504 492 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Bakshi1">[45]</xref>
RNA extraction, reverse transcription, and real-time PCR, together with the primers for GAPDH and 18S rRNA, were described previously [44]. The tested primers used to detect AMACR and Sp1 transcripts were AMf/AMr and Sp1f/Sp1r, respectively (Table 5). As the siRNA control, primers for GUSB and PP1A gene were used in the real-time RT-PCR and listed in the Table 5. The relative level of gene expression was calculated by the 2-DeltaDeltaCt method as described in detail in our previous studies [44],[45].
###end p 91
###begin title 92
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp1</italic>
Small Interfering RNA-Mediated Sp1 Knockdown
###end title 92
###begin p 93
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 360 363 348 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp1</italic>
###xml 537 538 525 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 740 744 728 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GUSB</italic>
###xml 749 753 737 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PP1A</italic>
###xml 290 293 <span type="species:ncbi:9685">cat</span>
###xml 401 404 <span type="species:ncbi:9685">cat</span>
1.5x105 HCT 116 cells were seeded at day -1 before transfection in each well of the 6-well plate. At day 0, transfection was performed with 5 microl of Lipofectamine 2000 (Invitrogen/ABI) and 7.5 microl of 20 microM siRNA per well according to the protocol. siSp1 (ON-TARGETplus SMARTpool, cat. no. L-026959-00, Dharmacon, Lafayette, CO) was used to knockdown Sp1 expression with Non-Targeting siRNA (cat. No. D-001210-01-05) as the control. At day 3, the cells either were collected for real-time RT-PCR analysis or were split at 1.5x105 cells per well. The second round of siRNA was performed on day 4 and analyzed on day 7. To demonstrate the specificity of siRNA knockdown effects, in parallel, the expression of two unrelated genes of GUSB and PP1A were analyzed.
###end p 93
###begin title 94
Ectopic Expression of Zinc Finger Protein 202 (ZNF202)
###end title 94
###begin p 95
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF202</italic>
###xml 52 56 52 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Wagner1">[27]</xref>
###xml 105 112 105 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t005">Table 5</xref>
Full-length coding sequence of ZNF202 m1 transcript [27] was amplified by primers NotIZ202 and Z202ApaI (Table 5) from LNCaP cDNA. The sequencing-verified fragment was subcloned into pcDNA4/His/Max A expression vector (Invitrogen). For real-time RT-PCR, the expression plasmid was transfected into HCT 116 in the 6-well plate with the Nucleofector Kit and Nucleofector II device from Amaxa (Gaithersburg, MD).
###end p 95
###begin title 96
Gel Mobility Shift Assay
###end title 96
###begin p 97
###xml 30 37 30 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t005">Table 5</xref>
###xml 977 979 935 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
Probe sequences were shown in Table 5. Complementary single-strand DNA oligos were annealed in 1xPCR buffer (20 mM Tris-HCl, 50 mM KCl, pH 8.4) in a water-filled heat block. The annealing mixture was heated at 95degreesC for 3 min and cooled to below 30degreesC in 1 hr to generate 50 microM double-strand oligo. The double-strand oligos showed a single and stronger band in 3% agarose gel, and located at a different position than the single-strand oligos (photos not shown). HCT 116 cells nuclear extract was prepared by Nuclear Extract Kit (Active Motif, Carlsbad, CA) according to the manufacturer's instructions. Three microg of nuclear extract (1 microl) was used in each binding assay at 18degreesC in 10 microl. The assays were carried out according to the protocol described in the Gel Shift Assay System (Promega) with the following modifications: Probe labeling was performed with 10 U T4 polynucleotide kinase (New England Biolabs, Ipswich, MA) and 2 microl [gamma-32P]ATP (3,000 Ci/mmol at 10 mCi/ml, Perkin Elmer, Waltham, MA) in a total volume of 10 microl at 37degreesC for 20 min. Electrophoresis of DNA-protein complexes was resolved in 6% DNA Retardation gel (Invitrogen) using 4degreesC 0.5x TBE buffer at 250 V for approximately35 min. Dried gels were exposed to X-ray film at -80degreesC for approximately1 hr and the images were captured by a digital camera.
###end p 97
###begin title 98
Genbank Accession Numbers
###end title 98
###begin p 99
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 380 385 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 570 575 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 591 600 591 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF202 m1</italic>
###xml 618 621 618 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp1</italic>
###xml 639 643 639 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GUSB</italic>
###xml 665 669 665 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PP1A</italic>
Five newly identified sequences of AMACR promoter variants with deletion/mutation at CpG hotspots were deposited into the Genbank (). The accession numbers for these variants are from EF636492 to EF636496, which represent a CG3 deletion, a CG3 mutation, a CG10 deletion, CG3 and 10 double-deletions, and a CG12-16 deletion, respectively. In addition, the accession number for the AMACR promoter from the Genbank reference assembly and Celera assembly are NT_006576.15 and NW_922562.1, respectively. The transcript reference sequences are NM_014324.4 and NM_203382.1 for AMACR, NM_003455 for ZNF202 m1, NM_138473.2 for Sp1, NM_000181.2 for GUSB, and NM_021130.3 for PP1A.
###end p 99
###begin title 100
Bioinformatics Analyses
###end title 100
###begin p 101
###xml 356 360 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Rozen1">[46]</xref>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 508 512 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000334-Cartharius1">[31]</xref>
###xml 759 766 759 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t005">Table 5</xref>
###xml 771 780 771 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g002">Figure 2B</xref>
Extensive gene analyses were carried out with GeneCards (). BLAST () was used to compare the sequence against Genbank. CGI was identified by MethPrimer at . Gene exon and intron information was obtained from Blat (). PCR primers, except for real-time RT-PCR negative control (Real Time Primers, Elkins Park, PA) and bisulfite PCR, were designed by Primer3 [46] at . The sequencing data were analyzed by ClustalW at . Putative TF binding sites in AMACR promoter deletion hotspots were scanned by MatInspector [31]. MatInspector utilizes transcription factor knowledge base to locate putative TF binding sites in sequence and minimize the number of false positive hits, but requires further confirmation through wet-bench works. It defines the "core sequence" (Table 5 and Figure 2B) of a putative binding site as the consecutive highest conserved positions in the DNA binding site.
###end p 101
###begin title 102
Statistical Analyses and Hierarchical Cluster Analysis
###end title 102
###begin p 103
###xml 220 228 220 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g001">Figure 1</xref>
###xml 391 399 391 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post hoc</italic>
###xml 553 560 553 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000334-t002">Table 2</xref>
###xml 904 905 904 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1369 1370 1367 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The hierarchical cluster analysis was based on the average linkage principle, and the absolute number of co-occurrences of different CG deletions was based on the similarity measure. The differences in AMACR expression (Figure 1) in the microdissected foci were compared among the different histologic categories using a one-way analysis of variance (nonparametric), followed by Tukey's HSD post hoc test for comparisons of all classes of lesions against normal cryptal cells. The analysis of CG12-16 deletion among the different histologic categories (Table 2) was carried out by SAS Proc Genmod software that assuming a log link and robust standard error estimation. The program estimates and tests differences between groups with respect to the proportion of deletion. A generalized linear model of binomial proportions was analyzed to detect differences. In other experiments, a two-tailed, unpaired t-test was performed between two groups. Except else where mentioned, the columns with error bars in the figures represent mean+/-95% confidence interval. For the CG12-16 deletion polymorphism study, Hardy-Weinberg equilibrium was used to test if specific disturbing influences are introduced to the samples, and chi-square test was used to exam genotypic and allelic differences between male and female. In all the analyses in this paper, unless otherwise stated, p<0.05 was considered as statistically significant.
###end p 103
###begin title 104
Supporting Information
###end title 104
###begin p 105
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 123 131 123 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000334-g003">Figure 3</xref>
Cluster analyses of mutation and the overall aberrations in AMACR promoter CGI. The same approach was used as indicated in Figure 3. Mutation basically occurred at CG3 and 10 in the LCM-captured colon samples, whereas the overall aberrations of deletion, methylation and mutation were at CG3, 10, and 12-16.
###end p 105
###begin p 106
(0.12 MB TIF)
###end p 106
###begin p 107
Click here for additional data file.
###end p 107
###begin p 108
###xml 112 117 112 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 324 329 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 523 528 523 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 586 591 586 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 905 910 905 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AMACR</italic>
###xml 981 986 <span type="species:ncbi:9606">human</span>
Quality control of bisulfite treatment, PCR, and sequencing. A: Representative bisulfite sequencing result with AMACR promoter short deletion at CG12-16 as an example. No CG compression was observed in the sequencing chromatogram. The peaks are discrete with clean background. The Cs (highlighted in red) in the "wild-type" AMACR promoter sequence were converted to Ts, demonstrating the complete bisulfite modification and hypomethylation of the CGI. B, Left: Bisulfite-specific PCR with the wild-type and CG12-16 deleted AMACR promoter as the template. The templates were cloned from AMACR promoter with the sequence verified. W, wild-type DNA template; D: template with CG12-16 deletion; (-): No template control. M: DNA marker. B, Right: Multiple bisulfite PCR assays demonstrating consistent size differences from samples carrying alleles with or without a deletion of CG12-16. C: Both the wild-type AMACR promoter sequence and the CG12-16 deleted sequence were identified in human genome assembly. NT_006576.15: reference assembly; NW_922562.1: Celera assembly.
###end p 108
###begin p 109
(1.28 MB TIF)
###end p 109
###begin p 110
Click here for additional data file.
###end p 110
###begin p 111
Putative deletion mechanisms at the CG hotspots. A: CpG methylation-mediated mutation involved in the deletion at CG3 and 10. CG3 and 10 are the methylation hotspots. Methylated C is the hotspot of modification or spontaneous deamination that may result in the deletion caused by repairing deficiency. B: Slipped-strand mispairing involved in the deletion at CG12-16. Two direct repeats of 7 nt (bold) were located downstream of the CG11 (underlined). Forward slippage, usually 2-3 bp within the direct repeats during DNA replication, leads to the 20-bp deletion.
###end p 111
###begin p 112
(0.25 MB TIF)
###end p 112
###begin p 113
Click here for additional data file.
###end p 113
###begin p 114
We thank Ms. Hong Xiao for her superb technical assistance in the work, Dr. Linda Levin for the analysis using SAS software, and Drs. Yuet-Kin Leung, Ying-Wai Lam, Shao-Chun Wang, and Huifeng Xi for their helpful discussion.
###end p 114
###begin title 115
References
###end title 115
###begin article-title 116
###xml 98 106 <span type="species:ncbi:9606">patients</span>
Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disorders.
###end article-title 116
###begin article-title 117
Fatty acid synthase: a metabolic oncogene in prostate cancer?
###end article-title 117
###begin article-title 118
Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer.
###end article-title 118
###begin article-title 119
Design, synthesis, and in vitro testing of alpha-methylacyl-CoA racemase inhibitors.
###end article-title 119
###begin article-title 120
A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer.
###end article-title 120
###begin article-title 121
Meat and dairy consumption and subsequent risk of prostate cancer in a US cohort study.
###end article-title 121
###begin article-title 122
Food groups and colorectal cancer risk.
###end article-title 122
###begin article-title 123
P504S: a new molecular marker for the detection of prostate carcinoma.
###end article-title 123
###begin article-title 124
###xml 52 57 <span type="species:ncbi:9606">human</span>
Identification of differentially expressed genes in human prostate cancer using subtraction and microarray.
###end article-title 124
###begin article-title 125
Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.
###end article-title 125
###begin article-title 126
Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker.
###end article-title 126
###begin article-title 127
Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer.
###end article-title 127
###begin article-title 128
Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
###end article-title 128
###begin article-title 129
Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: astudy of 761 cases.
###end article-title 129
###begin article-title 130
alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
###end article-title 130
###begin article-title 131
alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation.
###end article-title 131
###begin article-title 132
###xml 78 83 <span type="species:ncbi:9606">human</span>
Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions.
###end article-title 132
###begin article-title 133
Alpha-methylacyl-CoA racemase/P504S overexpression in colorectal carcinoma is correlated with tumor differentiation.
###end article-title 133
###begin article-title 134
A dietary enzyme: alpha-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma.
###end article-title 134
###begin article-title 135
Utility of alpha-methylacyl coenzyme A racemase (p504s antibody) as a diagnostic immunohistochemical marker for cancer.
###end article-title 135
###begin article-title 136
Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
###end article-title 136
###begin article-title 137
A genetic model for colorectal tumorigenesis.
###end article-title 137
###begin article-title 138
Branched fatty acids in dairy and beef products markedly enhance alpha-methylacyl-CoA racemase expression in prostate cancer cells in vitro.
###end article-title 138
###begin article-title 139
Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer.
###end article-title 139
###begin article-title 140
Sequence variation in alpha-methylacyl-CoA racemase and risk of early-onset and familial prostate cancer.
###end article-title 140
###begin article-title 141
Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma.
###end article-title 141
###begin article-title 142
###xml 51 56 <span type="species:ncbi:9606">human</span>
A broad role for the zinc finger protein ZNF202 in human lipid metabolism.
###end article-title 142
###begin article-title 143
###xml 88 93 <span type="species:ncbi:9606">human</span>
Characteristics of polymorphism at a VNTR locus 3' to the apolipoprotein B gene in five human populations.
###end article-title 143
###begin article-title 144
Identification of an OCT4 and SRY regulatory module using integrated computational and experimental genomics approaches.
###end article-title 144
###begin article-title 145
E2F in vivo binding specificity: Comparison of consensus versus nonconsensus binding sites.
###end article-title 145
###begin article-title 146
MatInspector and beyond: promoter analysis based on transcription factor binding sites.
###end article-title 146
###begin article-title 147
Cancer epigenetics and methylation.
###end article-title 147
###begin article-title 148
Molecular biology in colorectal cancer.
###end article-title 148
###begin article-title 149
ZNF202 is inversely regulated with its target genes ABCA1 and apoE during macrophage differentiation and foam cell formation.
###end article-title 149
###begin article-title 150
Zinc Finger Protein 202: a new candidate gene for ischemic heart disease: The Copenhagen City Heart Study.
###end article-title 150
###begin article-title 151
Association between adenomas of rectosigmoid colon and metabolic syndrome features in a Chinese population.
###end article-title 151
###begin article-title 152
###xml 130 134 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice.
###end article-title 152
###begin article-title 153
High protein, saturated fat and cholesterol diet, and low levels of serum lipids in colorectal cancer.
###end article-title 153
###begin article-title 154
Mutagenesis at methylated CpG sequences.
###end article-title 154
###begin article-title 155
###xml 35 40 <span type="species:ncbi:9606">human</span>
The structure and evolution of the human beta-globin gene family.
###end article-title 155
###begin article-title 156
###xml 108 113 <span type="species:ncbi:9606">human</span>
A novel mechanism generating short deletion/insertions following slippage is suggested by a mutation in the human alpha2-globin gene.
###end article-title 156
###begin article-title 157
Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
###end article-title 157
###begin article-title 158
###xml 97 102 <span type="species:ncbi:9606">human</span>
Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma.
###end article-title 158
###begin article-title 159
AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells.
###end article-title 159
###begin article-title 160
Transcriptome analyses in normal prostate epithelial cells exposed to low-dose cadmium: oncogenic and immunomodulations involving the action of tumor necrosis factor.
###end article-title 160
###begin article-title 161
Primer3 on the WWW for general users and for biologist programmers.
###end article-title 161
###begin p 162
The authors have declared that no competing interests exist.
###end p 162
###begin p 163
This work was supported by internal funding from the University of Cincinnati to SMH; NIH grants CA015776, CA062269, and CA112532 to SMH; and U.S. Army Prostate Cancer Program grant W81XWH-06-1-0433 to SMH.
###end p 163

